Business Development for the Biotechnology and Pharmaceutical Industry
Autor Martin Austinen Limba Engleză Hardback – 28 apr 2008
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 280.36 lei 22-36 zile | +19.36 lei 5-11 zile |
Taylor & Francis – 24 iun 2024 | 280.36 lei 22-36 zile | +19.36 lei 5-11 zile |
Hardback (1) | 765.62 lei 43-57 zile | |
Taylor & Francis – 28 apr 2008 | 765.62 lei 43-57 zile |
Preț: 765.62 lei
Preț vechi: 1028.94 lei
-26% Nou
Puncte Express: 1148
Preț estimativ în valută:
146.52€ • 152.20$ • 121.71£
146.52€ • 152.20$ • 121.71£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780566087813
ISBN-10: 0566087812
Pagini: 208
Ilustrații: Illustrations
Dimensiuni: 174 x 246 x 22 mm
Greutate: 0.6 kg
Ediția:New ed
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom
ISBN-10: 0566087812
Pagini: 208
Ilustrații: Illustrations
Dimensiuni: 174 x 246 x 22 mm
Greutate: 0.6 kg
Ediția:New ed
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom
Notă biografică
Martin Austin is Managing Director of TransformRx GmbH which he formed in 2005 to provide business advice to clients regarding investment and business development. He is also a Partner in MarraM Advisors sarl and Chairman of RSA AG. He was previously a Principal in the Paul Capital Partners Royalty Funds a USA based specialist in Secondary Private Equity and Alternative Asset Investments and before that as Head of Business Development for the Pharmaceuticals Division at F.Hoffmann-La Roche. He has had a broad ranging career in the Pharmaceutical industry starting as a Medical Representative in 1977 he progressed through Sales and Marketing roles with GD Searle in the early 80s to become Business Development Manager with Lorex Pharmaceuticals and then became a consultant with Marketing Improvements before leaving to become a founding Director of Machine Intelligence Technologies. Later he took over Business Development for the Dendrite organisation before being appointed Managing Director of MHIG Ltd an international joint venture in Market Research and Consulting prior to joining Roche. After 30 years of experience at all levels in the industry he has a unique background and perspective from which to address this book.
Cuprins
Foreword; The role of business development; Planning the portfolio; Identifying the needs; Profiling and searching for opportunities; Modelling and valuation; Structuring the value; Due diligence and negotiations; Sealing the deal - the contract; Making the transaction work; Glossary; Index.
Recenzii
'Business Development is an integral part of business in the Pharmaceutical business today, in terms of contributing to innovation; partnering on assets and indeed asset management more broadly. As the industry consolidates, yet science still grows exponentially, Martin has drawn together a thoughtful framework to help the many people with diverse skills and backgrounds approach this complex topic.' William M. Burns, CEO Pharmaceuticals Division, Roche ’...Hence, especially for people who are interested in this industry, this book offers an excellent introduction.’ - Dr. Alexander Brem, Academici.com (Translated from German)
Descriere
In recognition of the sparse information available to practitioners in the field of business development, Martin Austin has drawn on his 30 years of experience in the pharmaceutical industry to provide this highly practical guide spanning the complete process. Based on the well-established training programme he has developed and delivers to pharmaceutical executives from across the world, this book will help expand your knowledge in this immense area.